Arrow CVC 2 Lumen Pediatric Set: Incorrect Priming Volume Hazard
Arrow recalls pediatric central venous catheter sets with incorrect priming volume and flow rates. Affected units sold in specific lots; contact Arrow for details.
Lower-risk recall
The lidstock states the incorrect priming volume and flow rates.
Contact the company
What happened, in plain English
Arrow is recalling pediatric central venous catheter sets that have incorrect priming volume and flow rates as stated on the lidstock. This could lead to improper use during medical procedures if the device is used without correction. Read more at govinfonow.com/recall/69476-arrow-cvc-2-lumen-pediatric-set-incorrect-priming-volume-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/69476-arrow-cvc-2-lumen-pediatric-set-incorrect-priming-volume-hazard · Updated August 20, 2026 · FDA enforcement record: FDA #Z-0723-2019
Cite this page
“Arrow CVC 2 Lumen Pediatric Set: Incorrect Priming Volume Hazard.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69476-arrow-cvc-2-lumen-pediatric-set-incorrect-priming-volume-hazard. Based on FDA recall #Z-0723-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0723-2019%22&limit=1).
Why it’s dangerous
The lidstock provides incorrect priming volume and flow rates, which could lead to improper use during medical procedures. This might cause complications if the device is used without adjusting for the errors.
Who’s affected
Healthcare providers using the Arrow CVC 2 Lumen Pediatric Set for short-term central venous access. Patients receiving treatments like chemotherapy or blood transfusions are at risk if the device is used incorrectly.
How to tell if you have this one
Check for the product name 'Arrow CVC 2 Lumen, Pediatric Two-Lumen Central Venous Cauterization Set with Blue FlexTip Catheter, 4 Fr 2 Lumen 5cm'. Affected units are in lots 14F18F0336 and 14F18E0121.
- Brand
Arrow- Category
Medical device
What to do — step by step
Check Product Lot
Identify the lot number on the product packaging; affected lots are 14F18F0336 and 14F18E0121.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Worldwide distribution: US (nationwide) distribution to state of: FL and to countries of: Argentina, Canada, Chile, Columbia, Costa Rica, Dominican Republic, Ecuador, and Peru.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 19 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0723-2019 (November 14, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0723-2019 to see it in context.
- Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.